NHS National Framework for Transition products (Nilotinib and Ticagrelor)
key details
| Value | £29,042,000 (£34,850,400 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West |
| Deadline | 9 Jun 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-04ff90 |
Awards (15)
This procurement was awarded to 15 suppliers. Values shown are per-award; the notice total is £29,042,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £22,097,000 | 11 Jun 2025 | active |
| ACCORD-UK LTD shared | £22,097,000 | 11 Jun 2025 | pending |
| AstraZeneca shared | £22,097,000 | 11 Jun 2025 | active |
| ASTRAZENECA UK LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| C. S. T. PHARMA LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| Dr.Reddy's Laboratories (UK) Limited shared | £22,097,000 | 11 Jun 2025 | active |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| MSN Laboratories Europe Limited shared | £22,097,000 | 11 Jun 2025 | active |
| MSN LABORATORIES EUROPE LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| Novartis Pharmaceuticals UK Ltd shared | £22,097,000 | 11 Jun 2025 | active |
| ZENTIVA PHARMA UK LIMITED shared | £22,097,000 | 11 Jun 2025 | pending |
| Zentiva Pharma UK Ltd shared | £22,097,000 | 11 Jun 2025 | active |
| Zydus Pharmaceuticals UK Ltd shared | £22,097,000 | 11 Jun 2025 | active |
| ZYDUS PHARMACEUTICALS UK LTD shared | £22,097,000 | 11 Jun 2025 | pending |
description
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025
Offer reference number: CM/TNS/24/5721
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5721/01 - Nilotinib and Ticagrelor
Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)
Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)
Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
Additional Unsuccessful supplier not listed due to technical error:
Torrent Pharma (UK) Ltd
documents
- https://www.find-tender.service.gov.uk/Notice/019302-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/019321-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-1203 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
7 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 9 Apr 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 013938-2025 |
| 9 Apr 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 013939-2025 |
| 7 May 2025 | Tender notice (UK4) | Procurement Act 2023 | 019302-2025 |
| 7 May 2025 | Tender notice (UK4) | Procurement Act 2023 | 019321-2025 |
| 11 Jul 2025 | Contract award (UK6) | Procurement Act 2023 | 039171-2025 |
| 11 Jul 2025 | Contract award (UK6) | Procurement Act 2023 | 039270-2025 |
| 20 Aug 2025 | Contract details (UK7) | Procurement Act 2023 | 049985-2025 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.